ישראל - עברית - Ministry of Health

eldan electronic instruments co ltd, israel - sodium iodide (131 i) - קפסולה קשיחה - sodium iodide (131 i) 37 - 5550 mbq - sodium iodide (131i) - sodium iodide (131i) - theracap 131 is a radioiodine thyroid therapy indicated for: 1. treatment of graves' disease, as well as focal or disseminated autonomies of the thyroid.2.treatment of papillary and follicular thyroid carcinomas including metastases. - whole-body-scintigraphy for monitoring papillary or follicular thyroid carcinoma. sodium iodide 131 therapy is often combined with surgical intervention and with antithyroid medications.

ישראל - עברית - Ministry of Health

דוידוף א.א מסחר בינלאומי - רופא

ישראל - עברית - Ministry of Health

teva israel ltd - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or

ישראל - עברית - Ministry of Health

dexcel ltd, israel - cenobamate - טבליות מצופות פילם - cenobamate 100 mg - cenobamate

ישראל - עברית - Ministry of Health

dexcel ltd, israel - cenobamate - טבליה - cenobamate 12.5 mg - cenobamate

ישראל - עברית - Ministry of Health

dexcel ltd, israel - cenobamate - טבליות מצופות פילם - cenobamate 150 mg - cenobamate

ישראל - עברית - Ministry of Health

dexcel ltd, israel - cenobamate - טבליות מצופות פילם - cenobamate 200 mg - cenobamate

ישראל - עברית - Ministry of Health

dexcel ltd, israel - cenobamate - טבליות מצופות פילם - cenobamate 25 mg - cenobamate

ישראל - עברית - Ministry of Health

dexcel ltd, israel - cenobamate - טבליות מצופות פילם - cenobamate 50 mg - cenobamate